microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ld products  coupon code and up to  off printer ink  ld products we detected that your javascript seem to be disabled you must have javascript enabled in your browser to utilize the functionality of this website tax season sale  off ink and toner shop now quick reorder track order government my printers help  create account or sign in free shipping on all orders over † lifetime  satisfaction guarantee free shipping on orders over † low flat rate shipping  only  on orders under † multiple fulfillment centers  so you get your order faster orders placed before pm usually ship the same day †applies to orders delivered to the contiguous us close learn more reliability for a lifetime  all of our ld brand compatible ink and toner cartridges are backed by a lifetime guarantee verified excellence  our cartridges have been tested for performance quality and page yield so you know you are getting the absolute best product available your happiness matters  in the event that you are dissatisfied with your purchase simply let us know  well do our best to make it right close learn more special offers  items ink  toner office supplies paper cleaning  breakroom technology office furniture featured ink  toner brands all categories hp canon epson brother lexmark dell xerox samsung more ink  toner brands konica pitney bowes kyocera ricoh kodak sharp okidata toshiba panasonic refill kits featured office supply categories all categories writing  correction general supplies binders  accessories filing supplies envelopes  forms calendars  planners boards  easels desk organizers more office supply categories bags  travel accessories mailing  shipping storage  organizers tools  equipment cash handling labeling  labeling systems teaching  art featured paper categories all categories copy  multiuse paper notebooks pads  filler paper adhesive note pads photo paper brochure  specialty paper cards  stationary colored paper wide format paper featured cleaning  breakroom categories all categories cleaning supplies cleaning equipment breakroom supplies healthcare supplies safety  security facility supplies climate control featured technology categories all categories printers office machines  electronics power  backup network  cables d printing peripherals  memory drives  media shredders  accessories more technology categories audio video players computer accessories radio  mobile technology software  utilities cameras  scanners ink refill kits telephone  communication multimedia players displays  digital projectors featured office furnitures categories all categories furniture collections desks  tables chairs chair mats  accessories office decor  lighting armoires  bookcases filing storage  accessories carts  stands furniture accessories panel systems  accessories menu call reorder cart ink  toner office supplies hp canon epson brother lexmark dell xerox samsung okidata konica shop all printer brands office supplies paper cleaning technology office furniture ink  toner office supplies paper cleaning  breakroom technology office furniture my printers sign in track your order create account help special offers back general office supplies ink  toner hp canon epson brother lexmark dell xerox samsung okidata konica shop all printer brands  off ink  toner plus free shipping on all orders over  coupon code ldp applied expires  excludes oem items applies to orders delivered to the contiguous us scroll down for details find printer supplies fast easy  hassle free ink  toner finder select a printer brand select a printer brand top brands brother canon epson hewlett packard hp lexmark xerox all brands az acom amt amano astrojet birmy graphics brother bryce canon casio compaq computer language res copystar dec dataproducts dell dymo eicon laser electronic forms epson gestetner hasler hewlett packard hp ibm infoprint imagen imagistics interface systems kodak konicaminolta kyoceramita lanier lasermaster lexmark mimaki muratec mutoh nec nashuatec neopost newgen north atlantic oce okidata olivetti olympia panasonic pitney bowes primera printronix rena ricoh riso risograph roland samsung savin secap sharp sindoh star micronics tallygenicom tandem telenorma tenofax texas instruments toshiba xerox brother canon epson hewlett packard hp lexmark xerox acom amt amano astrojet birmy graphics brother bryce canon casio compaq computer language res copystar dec dataproducts dell dymo eicon laser electronic forms epson gestetner hasler hewlett packard hp ibm infoprint imagen imagistics interface systems kodak konicaminolta kyoceramita lanier lasermaster lexmark mimaki muratec mutoh nec nashuatec neopost newgen north atlantic oce okidata olivetti olympia panasonic pitney bowes primera printronix rena ricoh riso risograph roland samsung savin secap sharp sindoh star micronics tallygenicom tandem telenorma tenofax texas instruments toshiba xerox select a printerfamily select a printer family select a printer model select a printer model submit shop ink  toner from these top printer brands shop by printer brand hp hp officejet pro  hp officejet pro  hp envy  shop hp ink canon canon pixma mx canon pixma mg canon pixma mg shop canon ink epson epson workforce wf epson workforce wf epson workforce wf shop epson ink brother brother mfcjdw brother mfcjdw brother mfcjdw shop brother ink lexmark lexmark x lexmark prospect pro lexmark pro shop lexmark ink dell dell vw dell hcdw dell cw color shop dell ink xerox xerox phaser  xerox workcentre  xerox workcentre  shop xerox ink samsung samsung xpress cw samsung xpress mfw samsung xpress cfw shop samsung ink konicaminolta konica bizhub ce konica bizhub ce konica pagepro mf shop konica ink okidata okidata microline  turbo okidata mbw okidata oki mcw shop okidata ink shop all printer brands adding to cart added to cart add to get free shipping your order qualifies for free shipping price qty subtotal free shipping on orders over  to the contiguous us orders placed before pm pst typically ship the same day cart summary edit cart items in cart estimated shipping contiguous us ships same day coupon will be applied in shopping cart view cart continue shopping customers also bought other social login facebook sign in google sign in linkedin sign in orbimed english  portfolio immunotherapy gene therapy gene editing the future of health sciences is closer than you think many technologies with the potential to cure disease are advancing rapidly how long can healthy humans live  years  years our portfolio companies are working hard to find out industry sector all biopharmaceutical diagnosticstools healthcare services medical device healthcare it region all asia middle east north america europe sort by alphabetical newest oldest acutus developing a novel electroanatomical mapping catheter more adaptimmune focused on the use of t cell therapy to treat cancer more adicet bio adicet bio inc is developing a novel universal immunecell more adimab fully integrated yeastbased antibody discovery maturation and more aeglea biotherapeutics developing novel treatments using engineered human amino more aerpio developing treatments for disorders of the vasculature with more affimed discovering and developing next generation antibody therapies more aige hospital a leading eye hospital chain in the central region of china more aims multispecialty tertiary care hospital in north india more ait applied immune technologies ait is a drug development more ak medical developing a novel electroanatomical mapping catheter for more alector developing antibody therapeutics to treat more alpine immune sciences alpine immune sciences is focused on developing novel more amoy diagnostics the leader in cancer molecular diagnostics in china more armo biosciences discovering and developing novel immunooncology drugs more arsanis biosciences developing antibody therapeutics for infectious diseases more arvinas arvinas is a pharmaceutical company focused on developing more ascendis pharma ascendis pharma develops differentifaated prodrug versions more atox bio atox bio is a late stage biotechnology company that develops more audentes therapeutics developing gene therapy products for rare diseases more augmedix augmedix commercializes a service that frees doctors from more avedro inc avedro is a privately held medical device and more avitide developing custom affinity purification solutions for more balance therapeutics balance therapeutics is an rd company focused on more bharat serums and vaccines developing and manufacturing a wide range of products such more biolinerx building a portfolio of products for various indications more bonovo orthopedics providing the latest orthopedic products to the more cbt pharmaceuticals a spinoff from crown biosciences dedicated to oncology more cerapedics developing and commercializing products for the orthopedic more chemclin a leader to provide affordable diagnostics products more chemomab chemomab is developing therapeutic antibodies as more cleave biosciences discovering and developing therapeutics targeting more clementia developing treatments for diseases of heterotopic more compass therapeutics compass therapeutics is seeking to cure various cancer more corvus pharmaceuticals developing novel immunotherapies for the treatment of cancer more credit pharma credit pharma is a central nervous system focused leading more crown bioscience a preclinical cro with leadership in translational oncology more dih a leading provider of robotics and intelligent systems more dimension therapeutics developing aav therapeutics for rare diseases more domain surgical develops and commercializes a thermal surgical energy more echosens french hightechnology company specializing in more eddingpharm commercializing a broad range of pharmaceutical products in more emendo biotherapeutics emendo develops biotherapeutics based on its novel gene editing more eurolife healthcare one of india’s leading manufacturers of intravenous iv fluids more futurx pharma incubator established with jj and takeda more gc aesthetics develops and manufactures breast and aesthetic implants for more gcrise pharmaceutical a leading chinese pharmaceutical company focused on women more genewiz a leading global genomics service company more glaukos transforming glaucoma therapy more good start genetics developing improved methods of prepregnancy testing more graybug vision graybug vision is developing products to reduce the frequency of more guardant health guardant health is a private diagnostics company focusing on more hls therapeutics hls therapeutics is a specialty pharmaceutical more igenica discovering and developing breakthrough more inspire medical systems developed implanted neurostimulation device for more intellia therapeutics intellia is a leading gene editing company focused on more intercept developing therapeutics for liver  metabolic diseases more invitae offering  genetic diagnostics for hereditary disorders more kala pharmaceuticals kala pharmaceuticals is a clinical stage pharmaceutical more keystone heart developing procedural tools and accessories for use during more laxmi dental leading dental laboratory in india manufacturing dental more logicbio logicbio develops gene therapy vectors for previously more loxo oncology developing targeted cancer therapies for more marinus pharmaceuticals marinus pharmaceuticals is a clinical stage more mdclone mdclone was founded to address one of the most critical more medigus developing innovative endoscopic procedures and devices more mid labs an innovative ophthalmic medical device company with more nabriva developing pleuromutilins a new class of antibiotics more natera provides preconception and prenatal genetic testing more nerre therapeutics nerre therapeutics is developing a portfolio of neurokinin more netmedscom netmedscom is a leading online pharmacy marketplace in india more nextcure nextcure is a biopharmaceutical company focused on more novellusdx a personalized medicine diagnostics company assessing the more nucleix nucleix develops manufactures and markets more nutrinia nutrinia treats rare diseases of the gi tract by developing more obseva sa obseva is a swissbased pharmaceutical company developing small more omniguide surgical develops and markets an advanced surgical energy delivery more oric pharmaceuticals oric pharmaceuticals is focused on discovering and more ornim medical developing devices monitoring hemoglobin blood more otic pharma oticpharma is seeking to develop ear nose and throat products more otonomy developing novel drug therapies for disorders of the inner more oxonc development conducting clinical studies of xalkori in ros advanced more pharmabcine developing fully human therapeutic antibodies for the more pharming group nv netherlandsbased public biotechnology company more pieris ag discovering and developing anticalins® a novel class more pionyr immunotherapeutics pionyr is developing cancer immunotherapies that target the more pmv pharma developing p modulators for the treatment of cancer more practice fusion a leading provider of electronic healthcare record services more principia biopharma developing novel therapeutics using reversible more promentis pharmaceuticals promentis is developing compounds for the treatment of cns more proteus digital health proteus is a private digital medicine platform company more rapid pathogen screening marketer of rapid pointofcare diagnostic tests more rdd pharma developing drugdevice combinations for the treatment more recro pharma clinical stage specialty pharmaceutical company more redhill biopharma developing late clinicalstage formulations and combinations more response biomedical corp manufactures and markets rapid onsite diagnostic tests more reviral reviral is an emerging ukbased biopharma aiming to more rhythm pharmaceuticals rhythm is a biopharmaceutical company developing more roka bioscience commercializing novel nucleic acid testing methods more rpharm rpharm us is a specialty pharmaceutical company focused on more scpharmaceuticals scpharmaceuticals is developing a portfolio of pharmaceutical more selecta biosciences developing firstinclass integrated synthetic more senico healthcare leading provider of kidney and specialty care services in the more sibone commercializing the ifuse implant system for minimally more sientra inc developing products for the plastic surgery and more sierra oncology sierra oncology is a clinical stage drug development company more sikka software enhancing practice economics and improving quality of care more singulex developing and commercializing the next generation of more smartzyme smartzyme innovation is a life science company using a more sonendo developing innovative devices for root canal treatment more steadymed steadymed is a specialty pharmaceutical company focused on the more strides shasun service provider to the global pharmaceutical industry more suraksha diagnostic leading diagnostic chain in east india more surya a prominent neonatal and pediatric care hospital chain more symbiomix therapeutics a new focus on womens health more syndax pharmaceuticals syndax is a latestage biopharmaceutical company more synlogic synlogic engineers synthetic biotics a new class of medicines more tela bio developing novel biologic mesh implant products more therachon therachon is a biotech company specialized in research and more tigertext provides secure messaging in healthcare applications more tp therapeutics tp therapeutics is a clinicalstage biopharmaceutical company more treato the voice of the patient  big data analytics of patient more tricida preclinical stage biopharmaceutical company focused on more true north developing novel therapies that selectively inhibit more turnstone biologics turnstone is developing a firstinclass engineered oncolytic more tyto tytocare provides the missing link in telehealth  a more unilife develops and supplies injectable drug delivery systems more upper biotech a leading poct diagnostics company in china more verona pharma verona pharma is a ukbased clinical stage biopharmaceutical more viewray developing next generation radiotherapy technologies more waterstone pharmaceuticals chinabased specialty pharmaceutical company more whale imaging developing and commercializing medical imaging solutions more xenon pharmaceuticals xenon is a clinicalstage biopharmaceutical company discovering more xtant medical xtant medical is a comprehensive supplier of orthopedic more zai labratory a leading biotech company based in china more load more our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team orbimed english  contact us orbimeds team includes over  experienced professionals with expertise in the life sciences industry medicine finance and law investors if you are an investor interested in learning more about our funds please contact carter neild or bill price at    or send us an email companies if you would like to meet with our team please send us a description of your firm and the type of financing you are seeking by email for general inquiries please contact us at      new york  lexington avenueat rd street th floornew york ny       san francisco  mission bay blvd southsuite san francisco ca       mumbai suite f  grand hyatt plazasantacruz eastmumbai  india       herzliya  medinat hayehudim stbuilding e th floorherzliya  israel      shanghai unit  raffles cityshanghai office tower xizang middle roadshanghai  pr china    our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team orbimed english  about us from biopharmaceuticals to medical devices diagnostics and healthcare services orbimed is scouting the globe for innovations that will help ensure humanity lives healthier longer and more productive lives we have been investing globally for over  years across the healthcare industry from earlystage private companies to large multinational corporations our team of over  distinguished scientific medical investment and other professionals manage approximately  billion across public and private company investments worldwide   life sciences focus the global healthcare industry sits at the intersection of several powerful longterm growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease these trends have caused a steady increase in the level of healthcare spending in the industrialized world led by the us which now spends over  of its gdp on healthcare the healthcare industrys powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities our strategies orbimed invests across the global healthcare industry from seedstage venture capital to large publiclytraded companies investments are made in one of three strategies public equity private equity and royalty opportunities public equity orbimed manages a series of public equity funds including longshort eventdriven funds and closedend investment trusts we invest across all types of publiclytraded companies from biopharmaceuticals to medical devices and healthcare services worldwide private equity orbimeds private equity strategy is broad and flexible investing from startups through growth equity orbimed is typically a lead investor seeking to help build our portfolio companies our geographic focus includes north america asia europe and israel royalty opportunities orbimed provides commercialstage healthcare companies with nondilutive structured debt capital additionally orbimed can monetize royalty streams providing valuable financing solutions to owners of intellectual property firm history to thrive organisms need to adapt and grow so do investment firms through  years of volatile changing investment environments weve embraced new opportunities and expanded our global footprint    orbimeds investment business was founded in new york city    launched our first longshort fund and made our first venture capital investment    launched our first dedicated venture capital fund    opened offices in san francisco and shanghai china    opened office in mumbai india    opened office in herzliya israel    launched our first dedicated royalty  credit fund    hired our th employee our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team orbimed asia partners ii lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active orbimed asia partners ii lp • new york ny • venture capital fund how do i update this listing orbimed asia partners ii is based out of new york the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from orbimed asia partners ii lp enter your email address below and choose submit your email cancel contact info orbimed asia partners ii lp  lexington avenue th floor new york ny     business phone  recent sec filings d filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  d pooled investment fund venture capital fund pooled investment fund interests    other issuers in filings name address no other issuers related parties included in filings name address relationship carl l gordon subscription required director jonathan t silverstein subscription required director na orbimed advisors ii limited subscription required executive officer na orbimed asia gp ii lp subscription required executive officer w carter neild subscription required director elevate your investments try it for free orbimed asia gp lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors orbimed asia gp lp check out list of companies and businesses related to orbimed asia gp lp find out orbimed asia gp lp address and contact details view other people related to orbimed asia gp lp  coworkers colleagues companions etc address  third avenue th floor new york  ny companies related to orbimed asia gp lp cikcompany namepositioncompany addressresponse biomedical corp  th avenue w vancouver vppkun run biotechnology inc cranfield green se calgary tm c orbimed asia gp lp on the web persons related to orbimed asia gp lp  response biomedical corpnamepositioncitywilliam j adamscfo  corporate secretary vancouvertsonis anastasiosvancouvertsonis anastasiosvancouverholler anthonyvancouverholler anthonyvancouverholler anthonyvancouverholler anthonyvancouverrichard canotevancouverseverson clintvancouverseverson clintvancouverseverson clintonvancouverwang davidvancouveranthony holler drvancouveranthony holler drvancouverdavid wang drvancouverdavid wang drvancouverjoseph keegan drvancouverjoseph keegan drvancouverpeter thompson drvancouverpeter thompson drvancouvermorris duanevancouvermorris duanevancouvermorris duanevancouverliming fuhangzhou zhejiang chinahangzhou joinstar medical instrument  reagent co ltdhangzhou zhejiang chinahangzhou lizhu medical instrument  reagent co ltdhangzhou zhejiang chinaanthony f hollerdirector vancouverwebb ianvancouversamuel d isalysamuel d isalynew yorksamuel d isalynew yorkpurvin jeffreyvancouverwang jonathanvancouverkeegan josephvancouverjoseph d keegandirector sunnyvalejoseph d keegansunnyvalejoseph d keegandirector vancouverbarbara kinnairdsteenchief executive officer vancouvershuster lewisvancouvershuster lewisvancouvershuster lewisvancouberkaler livleenvancouverkaler livleenvancouverkaler livleenvancouverpatricia massittivp  admin and corp comm vancouverorbimed advisors llcdirector orbimed advisors llc owner new yorkorbimed advisors ltdnew yorkorbimed advisors ltdnew yorkorbimed advisors ltdnew yorkorbimed capital gp iii llcnew yorkorbimed capital gp iii llcnew yorkorbimed capital gp iii llcnew yorkharris paulvancouverthompson petervancouverthompson petervancouverjeffrey l purvinvancouverbastiani richardvancouverbastiani richardvancouverbear richardvancouverbear richardvancouverbastiani richardvancouverbear richardvancouverkay svancouverkay svancouverkay svancouverclinton seversondirector clinton seversondirector vancouvertimothy patrick shannonvancouvertimothy patrick shannonsrvpworldwidesalesmarketing vancouverlewis shusterdirector san diegolewis shusterdirector vancouverpeter a thompsondirector bellevuepeter a thompsondirector vancouverpatrick toddvancouverpatrick toddvancouverpatrick toddvancouveranastasios tsoniscontroller vancouverdavid wangdirector vancouverjonathan jian wangdirector vancouveradams williamvancouverwenjie xuhangzhou zhejiang chinaxuyi zhouhangzhou zhejiang chinapersons related to orbimed asia gp lp  kun run biotechnology incnamepositioncitynancy t changnew yorkxueyun cuibeijingsamuel d isalynew yorkyan linbeijingchang nancynew yorkorbimed advisors llcnew yorkorbimed advisors ltdnew yorkye xiaoqunhaikou city hainan provincecui xueyunhaikou city hainan provincelin yanhaikou city hainan provincexiaoqun yebeijing potentially same personnamecitycountryorbimed asia gp lpnew yorknyorbimed asia gp lpnew yorkny orbimed advisors llc sc da filing concerning rpbif on  whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active schedule da filed by orbimed advisors llc total shares  subject company response biomedical corp  view complete ownership history backtest filed as of date  event date  overall  ownership  reporting persons name solevoting power sharedvoting power soledispositive power shareddispositive power aggregateamount owned percentof class orbimed advisors llc       orbimed advisors limited       orbimed asia gp lp       orbimed capital gp iii llc       samuel d isaly       view original filing on edgars raw filing contents txt   hdrsgml    accession number  conformed submission type sc da public document count  filed as of date  date as of change  group members orbimed advisors ltd group members orbimed asia gp lp group members orbimed capital gp iii llc group members samuel d isaly subject company company data company conformed name response biomedical corp central index key  standard industrial classification servicestesting laboratories  irs number  state of incorporation a fiscal year end  filing values form type sc da sec act  act sec file number  film number  business address street    th avenue w city vancouver state a zip vpp business phone  mail address street    th avenue w city vancouver state a zip vpp filed by company data company conformed name orbimed advisors llc central index key  irs number  state of incorporation de filing values form type sc da business address street   lexington avenue street  th floor city new york state ny zip  business phone   mail address street   lexington avenue street  th floor city new york state ny zip  sc da  ssscdahtm amendment no      united states securities and exchange commission washington dc  schedule d under the securities exchange act of  amendment no        response biomedical corp name of issuer   common shares without par value title of class of securities   l cusip number   orbimed advisors llc orbimed advisors limited orbimed asia gp lp orbimed capital gp iii llc samuel d isaly  lexington avenue th floor new york ny  telephone   attn alexander m cooper name address and telephone number of person authorized to receive notices and communications   november   date of event which requires filing of this statement   if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§de df or dg check the following box  ☐   note  schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits  see §db for other parties to whom copies are to be sent    the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page   the information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of  “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes           cusip no  l            names of reporting persons                   orbimed advisors llc  check the appropriate box if a member of a group see instructions a ☐ b ☐        sec use only            source of funds see instructions           na  check if disclosure of legal proceedings is required pursuant to items d or e          ☐  citizenship or place of organization                          delaware number of shares beneficially owned by each reporting person with  sole voting power              shared voting power                   see item   sole dispositive power              shared dispositive power              see item   aggregate amount beneficially owned by each reporting person                see item   check if the aggregate amount in row  excludes certain shares see instructions                            ☐ see item   percent of class represented by amount in row                     see item   type of reporting person see instructions             ia   cusip no  l            names of reporting persons                   orbimed advisors limited  check the appropriate box if a member of a group see instructions a ☐ b ☐        sec use only            source of funds see instructions           na  check if disclosure of legal proceedings is required pursuant to items d or e          ☐  citizenship or place of organization                          cayman islands number of shares beneficially owned by each reporting person with  sole voting power              shared voting power             see item   sole dispositive power              shared dispositive power             see item   aggregate amount beneficially owned by each reporting person                see item   check if the aggregate amount in row  excludes certain shares see instructions                        ☐ see item   percent of class represented by amount in row                     see item   type of reporting person see instructions             oo     cusip no  l            names of reporting persons                   orbimed asia gp lp  check the appropriate box if a member of a group see instructions a ☐ b ☐        sec use only            source of funds see instructions           na  check if disclosure of legal proceedings is required pursuant to items d or e          ☐  citizenship or place of organization                          cayman islands number of shares beneficially owned by each reporting person with  sole voting power              shared voting power         see item   sole dispositive power              shared dispositive power             see item   aggregate amount beneficially owned by each reporting person                see item   check if the aggregate amount in row  excludes certain shares see instructions                        ☐ see item   percent of class represented by amount in row                     see item   type of reporting person see instructions             oo     cusip no  l            names of reporting persons                   orbimed capital gp iii llc  check the appropriate box if a member of a group see instructions a ☐ b ☐        sec use only            source of funds see instructions           na  check if disclosure of legal proceedings is required pursuant to items d or e          ☐  citizenship or place of organization                          delaware number of shares beneficially owned by each reporting person with  sole voting power              shared voting power         see item   sole dispositive power              shared dispositive power             see item   aggregate amount beneficially owned by each reporting person                see item   check if the aggregate amount in row  excludes certain shares see instructions                        ☐ see item   percent of class represented by amount in row                    see item   type of reporting person see instructions             oo     cusip no  l            names of reporting persons                   samuel d isaly  check the appropriate box if a member of a group see instructions a ☐ b ☐        sec use only            source of funds see instructions           na  check if disclosure of legal proceedings is required pursuant to items d or e          ☐  citizenship or place of organization                          united states number of shares beneficially owned by each reporting person with  sole voting power              shared voting power         see item   sole dispositive power              shared dispositive power             see item   aggregate amount beneficially owned by each reporting person                see item   check if the aggregate amount in row  excludes certain shares see instructions                        ☐ see item   percent of class represented by amount in row                     see item   type of reporting person see instructions             in                         item   security and issuer   this amendment no  “amendment no ” to schedule d supplements and amends the statement on schedule d of orbimed advisors llc orbimed advisors limited orbimed asia gp lp orbimed capital gp iii llc and samuel d isaly originally filed on august   as amended by amendment no  to schedule d filed on october   amendment no  to schedule d filed on october   amendment no  to schedule d filed on january   amendment no  to schedule d filed on november   amendment no  to schedule d filed on january   amendment no  to schedule d filed on november   amendment no  to schedule d filed on january   and amendment no  to schedule d filed on june   as amended the “schedule d” and relating to the common shares without par value the “shares” of response biomedical corp a corporation continued under the laws of the province of british columbia the “issuer” or the “company” having its principal executive offices located at  — th avenue w vancouver bc vp p canada     item  identity and background   a this schedule d is being filed by orbimed advisors llc “orbimed advisors” orbimed advisors limited “orbimed limited” orbimed asia gp lp “orbimed asia” orbimed capital gp iii llc “orbimed capital” and samuel d isaly “isaly” collectively the “reporting persons”   b — c orbimed advisors a limited liability company organized under the laws of delaware and a registered investment adviser under the investment advisers act of  as amended is the managing member or general partner of certain entities as more particularly described in item  below  orbimed advisors has its principal offices at  lexington avenue th floor new york new york    orbimed limited a corporation organized under the laws of the cayman islands is the general partner of a limited partnership as more particularly described in item  below  orbimed limited has its principal offices at  lexington avenue th floor new york new york    orbimed asia a limited partnership organized under the laws of the cayman islands is the general partner of a limited partnership as more particularly described in item  below  orbimed asia has its principal offices at  lexington avenue th floor new york new york    orbimed capital a limited liability company organized under the laws of delaware is the general partner of a limited partnership as more particularly described in item  below  orbimed capital has its principal offices at  lexington avenue th floor new york new york    isaly a natural person owns a controlling interest in orbimed advisors  isaly has his principal business  lexington avenue th floor new york new york      the directors and executive officers of orbimed advisors orbimed limited orbimed asia and orbimed capital are set forth on schedules i ii iii and iv respectively attached hereto  schedules i ii iii and iv set forth the following information with respect to each such person   i            name   ii           business address   iii          present principal occupation of employment and the name principal business and address of any corporation or other organization in which such employment is conducted and   iv          citizenship   d — e during the last five years neither the reporting persons nor any person named in schedules i through iv has been i convicted in a criminal proceeding excluding traffic violations or similar misdemeanors or ii a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment decree or final order enjoining future violations of or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws   f isaly is a citizen of the united states   item   source and amount of funds or other consideration   not applicable item   purpose of transaction   item  of this schedule d is hereby amended and restated in its entirety as set forth below arrangement agreement on june   the issuer entered into a plan of arrangement the “arrangement agreement” with  bc ltd “acquireco” a company owned by certain orbimed funds and shanghai runda medical technology co ltd “runda” pursuant to which acquireco would acquire all of the outstanding shares except for shares held by certain rollover shareholders who will instead receive shares of the acquireco on a  ratio at a price of cdn  per share in cash “arrangement consideration” the consummation of the transactions contemplated by the arrangement agreement was subject to certain closing conditions including the adoption of the arrangement agreement by at least twothirds of the votes at the special meeting and certain regulatory court and stock exchange consents upon the consummation of the arrangement agreement the issuer would become a whollyowned subsidiary of acquireco     on september   at a special meeting of the company’s shareholders the company’s shareholders voted to approve the arrangement agreement and the consummation of the statutory plan of arrangement under the business corporations act british columbia pursuant to which acquireco would acquire all of the issued and outstanding common stock of the company the “arrangement” on september   the supreme court of british columbia approved the arrangement on november   the company consummated the arrangement pursuant to the terms of the arrangement agreement and the company became a whollyowned subsidiary of acquireco at the effective time of the arrangement the “effective time” each share of the company’s common stock without par value per share issued and outstanding immediately prior to the effective time other than certain excluded shares was converted into the right to receive cdn  in cash without interest and less any applicable withholding taxes as a result of the arrangement the company’s common stock has ceased to trade on the toronto stock exchange and from quotation on the otc market  the company intends to file with the sec a certification and notice of termination on form  to terminate or suspend its reporting obligations under sections a and d of the securities exchange act of  as amended as promptly as practicable rollover agreements concurrently with the execution of the arrangement agreement the acquireco entered into rollover agreements the “rollover agreements” with orbimed associates opi iii and oap collectively the “rollovers” pursuant to the rollover agreements the rollovers agreed among other things to contribute all of their shares in exchange for shares of acquireco                   the descriptions of the arrangement agreement and the rollover agreements set forth above in this item  do not purport to be complete and are qualified in their entirety by reference to the full text of the arrangement agreement and the rollover agreements which have been filed as exhibits t u and v and are incorporated herein by this reference except as set forth in this schedule d the reporting persons have not formulated any plans or proposals which relate to or would result in  a the acquisition by any person of additional securities of the issuer or the disposition of securities of the issuer b an extraordinary corporate transaction such as a merger reorganization or liquidation involving the issuer or any of its subsidiaries c a sale or transfer of a material amount of the assets of the issuer or any of its subsidiaries d any change in the present board of directors or management of the issuer including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board e any material change in the issuer’s capitalization or dividend policy of the issuer f any other material change in the issuer’s business or corporate structure g any change in the issuer’s charter or bylaws or other instrument corresponding thereto or other action which may impede the acquisition of control of the issuer by any person h causing a class of the issuer’s securities to be deregistered or delisted from a national securities exchange or to cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association i a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section g of the act or j any action similar to any of those enumerated above     item   interest in securities of the issuer   a — b see item  above as a result of the arrangement agreement and the rollover agreements as defined and described in item  of this schedule d the reporting persons no longer beneficially own any shares              c except as disclosed in item  none of the reporting persons has effected any transaction during the past sixty  days in any shares   d not applicable   e not applicable   item   contracts arrangements understandings or relationships with respect to securities of the issuer   in addition to the relationships between the reporting persons described in item  above orbimed capital is the sole general partner of opi iii pursuant to the terms of the limited partnership agreement of opi iii  pursuant to this agreement and relationship orbimed capital has discretionary investment management authority with respect to the assets of opi iii  such authority includes the power to vote and otherwise dispose of securities held by opi iii                          orbimed advisors is the sole managing member of orbimed capital pursuant to the terms of the limited liability company agreement of orbimed capital  pursuant to these agreements and relationships orbimed advisors and orbimed capital have discretionary investment management authority with respect to the assets of opi iii  such authority includes the power of orbimed capital to vote and otherwise dispose of securities held by opi iii   orbimed advisors is also the general partner of orbimed associates pursuant to the terms of the limited partnership agreement of orbimed associates  pursuant to this agreement and relationship orbimed advisors has discretionary investment management authority with respect to the assets of orbimed associates  such authority includes the power to vote and otherwise dispose of securities held by orbimed associates          orbimed asia is the sole general partner of oap pursuant to the terms of the limited partnership agreement of oap  orbimed limited is the sole general partner of orbimed asia pursuant to the terms of the limited partnership agreement of orbimed asia  orbimed limited established the committee by written resolutions adopted on july    pursuant to these agreements resolutions and relationships orbimed asia has discretionary investment management authority with respect to the assets of oap and such discretionary investment management authority is exercised through orbimed limited by action of the committee such authority includes the power to vote and otherwise dispose of securities held by oap      following consummation of the arrangement as defined and described in item  none of the reporting persons holds any shares       xiaoying ken xu and jonathan j wang employees of orbimed advisors are members of the issuer’s board and accordingly the reporting persons may have the ability to effect and influence control of the issuer        other than the agreements and the relationships mentioned directly above and in items  and  hereof to the best knowledge of the reporting persons there are no contracts arrangements understandings or relationships legal or otherwise among the persons named in item  and between such persons and any persons with respect to any securities of the issuer including but not limited to transfer or voting of any of the shares finder’s fees joint ventures loan or option arrangements puts or calls guarantees of profits division of profits or loss or the giving of withholding of proxies   item   material to be filed as exhibits   exhibit   title n   joint filing agreement dated as of december   by and among orbimed advisors llc orbimed advisors limited orbimed asia gp lp orbimed capital gp iii llc and samuel d isaly o   arrangement agreement dated as of june   by and among response biomedical corporation and  bc ltd a company owned by orbimed asia partners lp orbimed private investments iii lp and orbimed associates iii lp and shanghai runda medical technology co ltd incorporated by reference to exhibit  to the current report on form k filed by response biomedical corporation on june   t   rollover agreement dated as of june   by and among orbimed private investments iii lp and  bc ltd  incorporated by reference to exhibit t to amendment no  to schedule d filed by the reporting persons on june   u   rollover agreement dated as of june   by and among orbimed asia partners lp and  bc ltd incorporated by reference to exhibit u to amendment no  to schedule d filed by the reporting persons on june   v   rollover agreement dated as of june   by and among orbimed associates iii lp and  bc ltd incorporated by reference to exhibit v to amendment no  to schedule d filed by the reporting persons on june         signature   after reasonable inquiry and to the best of my knowledge and belief i certify that the information set forth in this statement is true complete and correct       dated  december   orbimed advisors llc                   by   s samuel d isaly       samuel d isaly       managing member             orbimed advisors limited                   by  s samuel d isaly       samuel d isaly       director             orbimed asia gp lp                   by orbimed advisors limited its general partner             by  s samuel d isaly       samuel d isaly       director             orbimed capital gp iii llc                   by orbimed advisors llc its managing member             by  s samuel d isaly       samuel d isaly       managing member             samuel d isaly             by  s samuel d isaly       samuel d isaly             schedule i     the names and present principal occupations of each of the executive officers and directors of orbimed advisors llc are set forth below unless otherwise noted each of these persons is a united states citizen and has a business address of  lexington avenue th floor new york ny  name position with reporting person principal occupation       samuel d isaly managing member managing member orbimed advisors llc       carl l gordon member member orbimed advisor llc       sven h borho german and swedish citizen member member orbimed advisors llc       jonathan t silverstein member member orbimed advisors llc       w carter neild member member orbimed advisors llc       geoffrey c hsu member member orbimed advisors llc       evan d sotiriou chief financial officer chief financial officer orbimed advisors llc                           schedule ii   the names and present principal occupations of each of the executive officers and directors of orbimed advisors limited are set forth below unless otherwise noted each of these persons is a united states citizen and has a business address of  lexington avenue th floor new york ny  name position with reporting person principal occupation       samuel d isaly director director orbimed advisors limited       carl l gordon director director orbimed advisors limited       sven h borho german and swedish citizen director director orbimed advisors limited       jonathan t silverstein director director orbimed advisors limited       w carter neild director director orbimed advisors limited       geoffrey c hsu director director orbimed advisors limited       jonathan j wang director director orbimed advisors limited       sunny sharma director director orbimed advisors limited       david g wang director director orbimed advisors limited       alexander m cooper director director orbimed advisors limited   schedule iii             the business and operations of orbimed asia gp lp are managed by the executive officers and directors of its sole general partner orbimed advisors limited set forth on schedule ii attached hereto                                       schedule iv          the business and operations of orbimed capital gp iii llc are managed by the executive officers and directors of its managing member orbimed advisors llc set forth in schedule i attached hereto                     elevate your investments try it for free insider trading  orbimed advisors llc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  orbimed advisors llc select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm loxo oncology inc loxo orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view purchase  pm audentes therapeutics inc bold orbimed advisors llcdirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm response biomedical corp rbm orbimed advisors llcorbimed capital gp iii llcisaly samuel dorbimed advisors ltdorbimed asia gp lpdirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm adaptimmune therapeutics plc adap orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view purchase  pm intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view purchase  pm dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view purchase  pm pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector    indirect view purchase  pm pieris pharmaceuticals inc pirs orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view purchase  pm mirati therapeutics inc mrtx orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view option award  pm nana intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector   indirect view conversion  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view other  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view conversion  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  secgems orbimed asia partners iii lp data feeds now available excel  csv  java  python etc database learn more orbimed asia partners iii lp info ownership filings   lexington avenue th floor new york  ny   usa  filing datecurrent and former nameschanged on date orbimed asia partners iii lp central index key cik  state of incorporation e country of incorporation cayman islands fiscal year end  form d related persons filings carl l gordon  david g wang  jonathan g wang  jonathan t silverstein  jonathan wang  orbimed advisors iii limited  orbimed asia gp iii lp  samuel d isaly  sunny sharma  sven h borho  w carter neild  db insider trading  orbimed capital gp iii llc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  orbimed capital gp iii llc select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm response biomedical corp rbm orbimed advisors llcorbimed capital gp iii llcisaly samuel dorbimed advisors ltdorbimed asia gp lpdirector owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view purchase  pm pieris pharmaceuticals inc pirs orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement    microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ld products  coupon code and up to  off printer ink  ld products we detected that your javascript seem to be disabled you must have javascript enabled in your browser to utilize the functionality of this website tax season sale  off ink and toner shop now quick reorder track order government my printers help  create account or sign in free shipping on all orders over † lifetime  satisfaction guarantee free shipping on orders over † low flat rate shipping  only  on orders under † multiple fulfillment centers  so you get your order faster orders placed before pm usually ship the same day †applies to orders delivered to the contiguous us close learn more reliability for a lifetime  all of our ld brand compatible ink and toner cartridges are backed by a lifetime guarantee verified excellence  our cartridges have been tested for performance quality and page yield so you know you are getting the absolute best product available your happiness matters  in the event that you are dissatisfied with your purchase simply let us know  well do our best to make it right close learn more special offers  items ink  toner office supplies paper cleaning  breakroom technology office furniture featured ink  toner brands all categories hp canon epson brother lexmark dell xerox samsung more ink  toner brands konica pitney bowes kyocera ricoh kodak sharp okidata toshiba panasonic refill kits featured office supply categories all categories writing  correction general supplies binders  accessories filing supplies envelopes  forms calendars  planners boards  easels desk organizers more office supply categories bags  travel accessories mailing  shipping storage  organizers tools  equipment cash handling labeling  labeling systems teaching  art featured paper categories all categories copy  multiuse paper notebooks pads  filler paper adhesive note pads photo paper brochure  specialty paper cards  stationary colored paper wide format paper featured cleaning  breakroom categories all categories cleaning supplies cleaning equipment breakroom supplies healthcare supplies safety  security facility supplies climate control featured technology categories all categories printers office machines  electronics power  backup network  cables d printing peripherals  memory drives  media shredders  accessories more technology categories audio video players computer accessories radio  mobile technology software  utilities cameras  scanners ink refill kits telephone  communication multimedia players displays  digital projectors featured office furnitures categories all categories furniture collections desks  tables chairs chair mats  accessories office decor  lighting armoires  bookcases filing storage  accessories carts  stands furniture accessories panel systems  accessories menu call reorder cart ink  toner office supplies hp canon epson brother lexmark dell xerox samsung okidata konica shop all printer brands office supplies paper cleaning technology office furniture ink  toner office supplies paper cleaning  breakroom technology office furniture my printers sign in track your order create account help special offers back general office supplies ink  toner hp canon epson brother lexmark dell xerox samsung okidata konica shop all printer brands  off ink  toner plus free shipping on all orders over  coupon code ldp applied expires  excludes oem items applies to orders delivered to the contiguous us scroll down for details find printer supplies fast easy  hassle free ink  toner finder select a printer brand select a printer brand top brands brother canon epson hewlett packard hp lexmark xerox all brands az acom amt amano astrojet birmy graphics brother bryce canon casio compaq computer language res copystar dec dataproducts dell dymo eicon laser electronic forms epson gestetner hasler hewlett packard hp ibm infoprint imagen imagistics interface systems kodak konicaminolta kyoceramita lanier lasermaster lexmark mimaki muratec mutoh nec nashuatec neopost newgen north atlantic oce okidata olivetti olympia panasonic pitney bowes primera printronix rena ricoh riso risograph roland samsung savin secap sharp sindoh star micronics tallygenicom tandem telenorma tenofax texas instruments toshiba xerox brother canon epson hewlett packard hp lexmark xerox acom amt amano astrojet birmy graphics brother bryce canon casio compaq computer language res copystar dec dataproducts dell dymo eicon laser electronic forms epson gestetner hasler hewlett packard hp ibm infoprint imagen imagistics interface systems kodak konicaminolta kyoceramita lanier lasermaster lexmark mimaki muratec mutoh nec nashuatec neopost newgen north atlantic oce okidata olivetti olympia panasonic pitney bowes primera printronix rena ricoh riso risograph roland samsung savin secap sharp sindoh star micronics tallygenicom tandem telenorma tenofax texas instruments toshiba xerox select a printerfamily select a printer family select a printer model select a printer model submit shop ink  toner from these top printer brands shop by printer brand hp hp officejet pro  hp officejet pro  hp envy  shop hp ink canon canon pixma mx canon pixma mg canon pixma mg shop canon ink epson epson workforce wf epson workforce wf epson workforce wf shop epson ink brother brother mfcjdw brother mfcjdw brother mfcjdw shop brother ink lexmark lexmark x lexmark prospect pro lexmark pro shop lexmark ink dell dell vw dell hcdw dell cw color shop dell ink xerox xerox phaser  xerox workcentre  xerox workcentre  shop xerox ink samsung samsung xpress cw samsung xpress mfw samsung xpress cfw shop samsung ink konicaminolta konica bizhub ce konica bizhub ce konica pagepro mf shop konica ink okidata okidata microline  turbo okidata mbw okidata oki mcw shop okidata ink shop all printer brands adding to cart added to cart add to get free shipping your order qualifies for free shipping price qty subtotal free shipping on orders over  to the contiguous us orders placed before pm pst typically ship the same day cart summary edit cart items in cart estimated shipping contiguous us ships same day coupon will be applied in shopping cart view cart continue shopping customers also bought other social login facebook sign in google sign in linkedin sign in